GBM is largely considered an immunosuppressive tumor due to the activation of different immune escape strategies such as the upregulation of programmed death ligand 1 (PD-L1), indolamine 2,3 dioxygenase (IDO) and transforming growth factor-β (TGF-β) [6]. Here, IDO1 is linked to neoplasm.